Piet Ost
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Achard V, Putora P, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L, Lamanna G, Koutsouvelis N, Dipasquale G, Ost P, Meersschout S, Guckenberger M, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte F, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Zilli T. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiother Oncol 2022; 172:1-9.
Apr 26, 2022Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Apr 26, 2022Radiother Oncol 2022; 172:1-9
Achard Vérane, Putora Paul Martin, Zwahlen Daniel, Couñago Felipe, Scorsetti Marta, Eito Clara, Barrado Marta, Zapatero Almudena, Muto Paolo, Van De Voorde Lien, Lamanna Giorgio, Koutsouvelis Nikolaos, Dipasquale Giovanna, Ost Piet, Meersschout Sabine, Guckenberger Matthias, Jaccard Maud, Vanhoutte Frederik, Siva Shankar, Heikkilä Reino, Dirix Piet, Liefhooghe Nick, Otte François-Xavier, Gomez-Iturriaga Alfonso, Berghen Charlien, Shelan Mohamed, Conde-Moreno Antonio, López Campos Fernando, Papachristofilou Alexandros, Zilli Thomas
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Beck M, Li Q, Sumila M, Zaugg K, Guckenberger M, Ost P, Bosetti D, Reuter C, Gomez S, Khanfir K, Aebersold D, Ghadjar P, Schär C, Hayoz S, Papachristofilou A, Sassowsky M, Schär S, Mathier E, Halter M, Zwahlen D, Hölscher T, Arnold W, Polat B, Hildebrandt G, Müller A, Putora P, Pra A. Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial. Int J Radiat Oncol Biol Phys 2022; 113:80-91.
Jan 3, 2022Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Jan 3, 2022Int J Radiat Oncol Biol Phys 2022; 113:80-91
Beck Marcus, Li Qiyu, Sumila Marcin, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Bosetti Davide G, Reuter Christiane, Gomez Silvia, Khanfir Kaouthar, Aebersold Daniel M, Ghadjar Pirus, Schär Corinne, Hayoz Stefanie, Papachristofilou Alexandros, Sassowsky Manfred, Schär Sämi, Mathier Etienne, Halter Matthias, Zwahlen Daniel R, Hölscher Tobias, Arnold Winfried, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Pra Alan Dal
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Vogl U, Mottet N, Padhani A, Roach M, Rubin M, Sartor O, Small E, Smith M, Soule H, Sydes M, Tombal B, Omlin A, Gillessen S, James N, Halabi S, Beer T, Davis I, Shore N, Sweeney C, Ost P, Attard G, Bossi A, de Bono J, Drake C, Efstathiou E, Fanti S, Fizazi K, APCCC 2019 expert panel. Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. Eur J Cancer 2021; 160:24-60.
Nov 26, 2021Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Nov 26, 2021Eur J Cancer 2021; 160:24-60
Vogl Ursula M, Mottet Nicolas, Padhani Anwar R, Roach Mack, Rubin Mark, Sartor Oliver, Small Eric, Smith Matthew R, Soule Howard, Sydes Matthew R, Tombal Bertrand, Omlin Aurelius, Gillessen Silke, James Nicolas, Halabi Susan, Beer Tomasz M, Davis Ian D, Shore Neal D, Sweeney Christopher J, Ost Piet, Attard Gerhardt, Bossi Alberto, de Bono Johann, Drake Charles G, Efstathiou Eleni, Fanti Stefano, Fizazi Karim, APCCC 2019 expert panel
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Ghadjar P, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti D, Kaouthar K, Gomez S, Wust P, Thalmann G, Aebersold D, Sumila M, Schär C, Hayoz S, Bernhard J, Zwahlen D, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A, Plasswilm L, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. Eur Urol 2021; 80:306-315.
Jun 14, 2021Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Jun 14, 2021Eur Urol 2021; 80:306-315
Ghadjar Pirus, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Reuter Christiane, Bosetti Davide G, Kaouthar Khanfir, Gomez Silvia, Wust Peter, Thalmann George N, Aebersold Daniel M, Sumila Marcin, Schär Corinne, Hayoz Stefanie, Bernhard Jürg, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Plasswilm Ludwig, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Omlin A, Ryan C, Rubin M, Roach M, Reiter R, Pritchard C, Poon D, Parker C, Padhani A, O'Sullivan J, Ost P, Oh W, Murthy V, Murphy D, Mrabti H, Mottet N, Morris M, Saad F, Sade J, Zapatero A, van Oort I, Türkeri L, Tombal B, Taplin M, Sydes M, Sweeney C, Suzuki H, Steuber T, Sternberg C, Soule H, Smith M, Small E, Shore N, Scher H, Sartor O, Morgans A, Millman R, Evans C, Efstathiou E, Eeles R, Duran I, Drake C, de Bono J, Davis I, Clarke N, Chi K, Bristow R, Briganti A, Bossi A, Bjartell A, Beltran H, Beer T, Attard G, Fanti S, Feng F, Maluf F, Logothetis C, Leibowitz R, Khauli R, Kantoff P, Kanesvaran R, James N, Hussain M, Hofman M, Higano C, Heinrich D, Heidenreich A, Halabi S, Gleave M, Frydenberg M, Fizazi K, Gillessen S. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol 2020; 77:508-547.
Jan 27, 2020Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
Jan 27, 2020Eur Urol 2020; 77:508-547
Omlin Aurelius, Ryan Charles J, Rubin Mark, Roach Mack, Reiter Robert E, Pritchard Colin C, Poon Darren M C, Parker Chris, Padhani Anwar R, O'Sullivan Joe M, Ost Piet, Oh William K, Murthy Vedang, Murphy Declan G, Mrabti Hind, Mottet Nicolas, Morris Michael J, Saad Fred, Sade Juan Pablo, Zapatero Almudena, van Oort Inge, Türkeri Levent, Tombal Bertrand, Taplin Mary-Ellen, Sydes Matthew R, Sweeney Christopher, Suzuki Hiroyoshi, Steuber Thomas, Sternberg Cora N, Soule Howard, Smith Matthew, Small Eric, Shore Neal, Scher Howard I, Sartor Oliver, Morgans Alicia K, Millman Robin, Evans Christopher P, Efstathiou Eleni, Eeles Ros, Duran Ignacio, Drake Charles G, de Bono Johann, Davis Ian D, Clarke Noel, Chi Kim N, Bristow Rob G, Briganti Alberto, Bossi Alberto, Bjartell Anders, Beltran Himisha, Beer Tomasz M, Attard Gerhardt, Fanti Stefano, Feng Felix Y, Maluf Fernando, Logothetis Chris, Leibowitz Raya, Khauli Raja B, Kantoff Philip, Kanesvaran Ravindran, James Nicolas, Hussain Maha, Hofman Michael S, Higano Celestia Tia S, Heinrich Daniel, Heidenreich Axel, Halabi Susan, Gleave Martin, Frydenberg Mark, Fizazi Karim, Gillessen Silke
Consensus on molecular imaging and theranostics in prostate cancer
Fanti S, Montironi R, Ost P, O'Sullivan J, Padhani A, Schalken J, Scher H, Tombal B, van Moorselaar R, Van Poppel H, Vargas H, Walz J, Weber W, Wester H, Lecouvet F, Hicks R, Herrmann K, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, de Bono J, Fizazi K, Gillessen Sommer S, Gledhill S, Haberkorn U, Oyen W. Consensus on molecular imaging and theranostics in prostate cancer. Lancet Oncol 2018; 19:e696-e708.
Dec 1, 2018Consensus on molecular imaging and theranostics in prostate cancer
Dec 1, 2018Lancet Oncol 2018; 19:e696-e708
Fanti Stefano, Montironi Rodolfo, Ost Piet, O'Sullivan Joe M, Padhani Anwar R, Schalken Jack A, Scher Howard I, Tombal Bertrand, van Moorselaar R Jeroen A, Van Poppel Heindrik, Vargas Hebert Alberto, Walz Jochen, Weber Wolfgang A, Wester Hans-Jürgen, Lecouvet Frederic, Hicks Rodney J, Herrmann Ken, Minozzi Silvia, Antoch Gerald, Banks Ian, Briganti Alberto, Carrio Ignasi, Chiti Arturo, Clarke Noel, Eiber Matthias, de Bono Johann, Fizazi Karim, Gillessen Sommer Silke, Gledhill Sam, Haberkorn Uwe, Oyen Wim J G
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Omlin A, Ryan C, Rubin M, Roach M, Pritchard C, Parker C, Padhani A, Ost P, Oh W, Murthy V, Mottet N, Morris M, Morgans A, Maluf F, Saad F, Sartor O, Wiegel T, Valdagni R, Tombal B, Tannock I, Sydes M, Sweeney C, Suzuki H, Sternberg C, Soule H, Smith M, Shore N, Sella A, Scher H, Logothetis C, Kramer G, Khauli R, Dos Reis R, de Bono J, Davis I, Daugaard G, Clarke N, Chung B, Castellano D, Carver B, Bristow R, Bossi A, Beltran H, Beer T, Attard G, Drake C, Eeles R, Kellokumpu-Lehtinen P, Kantoff P, James N, Higano C, Heidenreich A, Halabi S, Gleave M, Frydenberg M, Fizazi K, Feng F, Fanti S, Evans C, Efstathiou E, Gillessen Sommer S. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2017
Jun 24, 2017Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Jun 24, 2017Eur Urol 2017
Omlin Aurelius, Ryan Charles, Rubin Mark A, Roach Mack, Pritchard Colin C, Parker Chris, Padhani Anwar R, Ost Piet, Oh William, Murthy Vedang, Mottet Nicolas, Morris Michael J, Morgans Alicia K, Maluf Fernando, Saad Fred, Sartor Oliver, Wiegel Thomas, Valdagni Riccardo, Tombal Bertrand, Tannock Ian, Sydes Matthew R, Sweeney Christopher, Suzuki Hiroyoshi, Sternberg Cora N, Soule Howard, Smith Matthew, Shore Neal, Sella Avishay, Scher Howard, Logothetis Chris, Kramer Gero, Khauli Raja B, Dos Reis Rodolfo Borges, de Bono Johann, Davis Ian D, Daugaard Gedske, Clarke Noel, Chung Byung Ha, Castellano Daniel, Carver Brett, Bristow Rob, Bossi Alberto, Beltran Himisha, Beer Tomasz M, Attard Gerhardt, Drake Charles G, Eeles Ros, Kellokumpu-Lehtinen Pirkko-Liisa, Kantoff Philip, James Nicolas, Higano Celestia S, Heidenreich Axel, Halabi Susan, Gleave Martin, Frydenberg Mark, Fizazi Karim, Feng Felix, Fanti Stefano, Evans Christopher P, Efstathiou Eleni, Gillessen Sommer Silke
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Ghadjar P, Kranzbühler H, Najafi Y, Ost P, Azinwi N, Reuter C, Bodis S, Kaouthar K, Budach V, Aebersold D, Thalmann G, Sumila M, Biaggi-Rudolf C, Stalder L, Hayoz S, Genitsch V, Zwahlen D, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A, Putora P, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
Jan 19, 2017Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Jan 19, 2017BJU Int 2017; 120:E45-E51
Ghadjar Pirus, Kranzbühler Helmut, Najafi Yousef, Ost Piet, Azinwi Ngwa C, Reuter Christiane, Bodis Stephan, Kaouthar Khanfir, Budach Volker, Aebersold Daniel M, Thalmann George N, Sumila Marcin, Biaggi-Rudolf Christine, Stalder Lukas, Hayoz Stefanie, Genitsch Vera, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Guckenberger Matthias, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
Sassowsky M, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold D, Plasswilm L, Azinwi N, Zwahlen D, Gut P, Hölscher T, Hildebrandt G, Müller A, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Ghadjar P. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 2013; 87:534-41.
Aug 22, 2013Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
Aug 22, 2013Int J Radiat Oncol Biol Phys 2013; 87:534-41
Sassowsky Manfred, Takacs Istvan, Reuter Christiane, Sumila Marcin, Manser Peter, Ost Piet, Böhmer Dirk, Pilop Christiane, Aebersold Daniel M, Plasswilm Ludwig, Azinwi Ngwa C, Zwahlen Daniel R, Gut Philipp, Hölscher Tobias, Hildebrandt Guido, Müller Arndt-Christian, Najafi Yousef, Kohler Götz, Kranzbühler Helmut, Guckenberger Matthias, Ghadjar Pirus